论文部分内容阅读
美国Genencor国际公司和伊土曼化学公司最近联合开发了一种方法,利用遗传工程从葡萄糖中制造抗坏血酸(维生素C),并拟合资建造一家世界规模的大型工厂,其地点即将选定。从谷物中制造的葡萄糖将被细菌发酵,直接制成2-酮-L-古洛糖酸(2-KLG)。这是一种关键中间体
US Genencor International and Itoman Chemicals recently jointly developed a method to use genetic engineering to manufacture ascorbic acid (vitamin C) from glucose and build it into a large-scale factory on a world-scale basis. Glucose produced from cereals will be fermented by bacteria and made directly into 2-keto-L-gulonic acid (2-KLG). This is a key intermediate